Evidence map›Paper›PMID 21666120›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2011

Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling.

Juozas A Zavadzkas, Rupak Mukherjee, William T Rivers, Risha K Patel, Evan C Meyer, Laurel E Black, Richard A McKinney, J Marshall Oelsen, Robert E Stroud, Francis G Spinale

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis.International journal of molecular sciences · 2020
    Review
  7. Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors.International journal of molecular sciences · 2020
    Article
  8. Review
  9. Review
  10. Matrix metalloproteinase collagenolysis in health and disease.Biochimica et biophysica acta. Molecular cell research · 2017
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cyclosporin A in left ventricular remodeling after myocardial infarction.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Juozas A ZavadzkasMedical University of South Carolina and Ralph H. Johnson Veteran's Affairs Medical Center, Charleston, South Carolina 29425, USA.
Rupak Mukherjee
William T Rivers
Risha K Patel
Evan C Meyer
Laurel E Black
Richard A McKinney
J Marshall Oelsen
Robert E Stroud
Francis G Spinale
Ralph H. Johnson VA Medical Center · USMedical University of South Carolina · US

Funding

COLLAGENASE INHIBITION IN HEART FAILURER01HL059165 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SPINALE, FRANCIS G · 1998 to 2010
$3.2M
Endothelin Receptors and Progression to Heart FailureR01HL057952 · NHLBI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI SPINALE, FRANCIS G · 1998 to 2011
$3.1M
Myocardial Protection and Matrix ProteasesR01HL095608 · NHLBI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI SPINALE, FRANCIS G · 2010 to 2013
$1.4M
NHLBI NIH HHS HL-057952NHLBI NIH HHS HL-059165NHLBI NIH HHS HL-095608NHLBI NIH HHS R01 HL057952NHLBI NIH HHS R01 HL059165NHLBI NIH HHS R01 HL095608
6 · The paper itself

Abstract

The membrane type 1 matrix metalloproteinase (MT1-MMP) is increased in left ventricular (LV) failure. However, the direct effects of altered MT1-MMP levels on survival, LV function, and geometry following myocardial infarction (MI) and the proteolytic substrates involved in this process remain unclear. MI was induced in mice with cardiac-restricted overexpression of MT1-MMP (MT1-MMPexp; full length human), reduced MT1-MMP expression (heterozygous; MT1-MMP(+/-)), and wild type. Post-MI survival was reduced with MT1-MMPexp and increased with MT1-MMP(+/-) compared with WT. LV ejection fraction was lower in the post-MI MT1-MMPexp mice compared with WT post-MI and was higher in the MT1-MMP(+/-) mice. In vivo localization of MT1-MMP using antibody-conjugated microbubbles revealed higher MT1-MMP levels post-MI, which were the highest in the MT1-MMPexp group and the lowest in the MT1-MMP(+/-) group. LV collagen content within the MI region was higher in the MT1-MMPexp vs. WT post-MI and reduced in the MT1-MMP(+/-) group. Furthermore, it was demonstrated that MT1-MMP proteolytically processed the profibrotic molecule, latency-associated transforming growth factor-1-binding protein (LTBP-1), and MT1-MMP-specific LTBP-1 proteolytic activity was increased by over fourfold in the post-MI MT1-MMPexp group and reduced in the MT1-MMP(+/-) group, which was directionally paralleled by phospho-Smad-3 levels, a critical signaling component of the profibrotic transforming growth factor pathway. We conclude that modulating myocardial MT1-MMP levels affected LV function and matrix structure, and a contributory mechanism for these effects is through processing of profibrotic signaling molecules. These findings underscore the diversity of biological effects of certain MMP types on the LV remodeling process.

Indexed as

AnimalsCollagenHeartImmunohistochemistryKaplan-Meier EstimateLatent TGF-beta Binding ProteinsMatrix Metalloproteinase 14MiceMice, KnockoutMyocardial InfarctionRNA, MessengerSmad2 ProteinSurvivalVentricular Function, LeftVentricular RemodelingCollagenLatent TGF-beta Binding ProteinsLtbp1 protein, mouseMatrix Metalloproteinase 14Mmp14 protein, mouseRNA, MessengerSmad2 ProteinSmad2 protein, mouse

Identifiers

PMID21666120
PMCPMC3197432
OpenAlexW2029513470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.